Extraordinary General Assembly: Invitation to Members
The Chairman and Executive Committee invite all members to attend an extraordinary General Assembly of Members which will be held at the NH Hotel du Grand Sablon (rue Bodenbroek 2/4, 1000 Brussels) on Friday, 27 March 2015 at 12.00 (noon).
The aim of this assembly is to extend the statutory goal of the society. The official invitation letter can be downloaded here.
Members who are unable to attend this extraordinary General Assembly of Members, can download a proxy here which is to be signed (with hand written mention “for proxy”), dated, and returned either by post to ESHRE Central Office, Meerstraat 60 Belgium, 1852 Grimbergen, Belgium (attn. Bruno Van den Eede) or by e-mail to email@example.com before 15/03/2015.
Current bylaws can be found here.
UK to allow mitochondrial donation
The UK is poised to become the world's first country to allow clinical trials of mitochondrial donation in couples known to be at high risk of passing on mitochondrial diseases to their children. The move follows a vote in the UK's lower Parliament (the House of Commons) which approved the measure by a considerable majority; if the measure now succeeds in passing the House of Lords and meeting the regulatory requirements of the HFEA, the first trials could begin towards the end of this year. The trials are likely to be at the Wellcome Trust Centre for Mitochondrial Research at Newcastle University, under the direction of Professor Doug Turnbull, which would need to apply for a research license from the HFEA.
The possibilities of preventing the transmission of mitochondrial diseases (which are said to affect around 2500 women in Britain) has already been the subject of a favourable public consultation by the HFEA.
Focus on Reproduction January 2015
The listening endometrium
Nick Macklon and Jan Brosens on the role of the ‘selective uterus’ in implantation
Look ahead to Lisbon
Emancipation or corporate constraint? Egg freezing as a perk of the job
Read the issue>
Human Reproduction : Editor's Highlight
Prof. Hans Evers, Editor-in-Chief of Human Reproduction casts an eye on the March 2015 issue and choses his own highlight.
Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency
Nao Suzuki, Nobuhito Yoshioka, Seido Takae, Yodo Sugishita, Midori Tamura, Shu Hashimoto, Yoshiharu Morimoto and Kazuhiro Kawamura
ESHRE’s first research grant has been awarded to a project designed to prevent the loss of female fertility during cancer treatment.
The grant - of €150,000 - will fund researchers at the Universities of Edinburgh and Rome Tor Vergata, led by Professor Norah Spears, to test the viability of tyrosine kinase inhibitors
in protecting the ovary from chemotherapyinduced damage. The project will use a novel ovarian culture system allowing highthroughput and rapid quantitative analysis.
MyESHRE is launched
MyESHRE, a new feature of the ESHRE website, has been developed for all ESHRE members and those interested in ESHRE activities. It is your personalised online area where your can manage your private and membership information.
The MyESHRE area will also allow you to download your invoices, confirmation letters, and other relevant personal documents. You will also be able to manage your subscriptions, announcements and ESHRE Update.
You can access your MyESHRE area with this link
(also clickable from the homepage of the ESHRE website).
To login in to your MyESHRE area you will need your ESHRE credentials that you can always retrieve from here